Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients

• Status: Recruiting
• Trial end date: 2021-11-15
• Target enrollment: 0
• Participant gender: All

Summary

In current analysis moderate to severely ill Covid-19 infected patients will be nebulized with nitroglycerin, and they will be compared with the standard nebulization

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Lahore
• Treatments: Nitroglycerin

Criteria

Inclusion Criteria:

Diagnosed admitted cases of Covid-19 degree of illness should be moderate to severe both male and female every age group

Exclusion Criteria:

allergic to nitroglycerin sudden drop in blood pressure not given consent